Erlotinib Completed Phase 2 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02057380A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial